We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Intraoperative Dexamethasone and Its Effect on Hyperglycemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03646916
Recruitment Status : Withdrawn (Lack of patients)
First Posted : August 24, 2018
Last Update Posted : January 22, 2021
Information provided by (Responsible Party):
Tarik Wasfie, MD, Ascension Genesys Hospital

Brief Summary:
To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus Drug: Dexamethasone Other: No dexamethasone Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Effect of Pre-Operative Dexamethasone Dose on the Post-Operative Management of Blood Sugar in Diabetic Patients
Actual Study Start Date : September 15, 2020
Actual Primary Completion Date : December 31, 2020
Actual Study Completion Date : December 31, 2020

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Dexamethasone Drug: Dexamethasone

Other: No dexamethasone

No Intervention: Non-treatment

Primary Outcome Measures :
  1. Post-operative blood sugar [ Time Frame: 24 hour Post surgery ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • documented history of Type I or Type II Diabetes Mellitus
  • scheduled for surgery that requires patients to be admitted for at least 24 hours post-surgery

Exclusion Criteria:

  • Patients on steroid therapy
  • Pregnant women
  • Patients at low risk for nausea/vomiting

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03646916

Layout table for location information
United States, Michigan
Genesys Regional Medical Center
Grand Blanc, Michigan, United States, 48439
Sponsors and Collaborators
Ascension Genesys Hospital
Layout table for additonal information
Responsible Party: Tarik Wasfie, MD, Principal Investigator, Ascension Genesys Hospital
ClinicalTrials.gov Identifier: NCT03646916    
Other Study ID Numbers: GRMC160010
First Posted: August 24, 2018    Key Record Dates
Last Update Posted: January 22, 2021
Last Verified: January 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dexamethasone acetate
BB 1101
Anti-Inflammatory Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Protease Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action